EARS

Auris Medical Stock Price

2.6727
0.0427 (1.62%)
Upgrade to Real-Time
Regular Market
2.6727
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Auris Medical Holding AG EARS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0427 1.62% 2.6727 15:37:27
Open Price Low Price High Price Close Price Prev Close
2.68 2.56 2.74 2.63
Bid Price Ask Price Spread News
2.67 2.68 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,037 770,482 $ 2.64 $ 2,033,297 1,615,404 0.65 - 6.575
Last Trade Time Type Quantity Stock Price Currency
15:37:27 100 $ 2.6727 USD

Auris Medical Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 18.96M 7.09M 1.56M $ - $ - -14.64 5.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Auris Medical News

Date Time Source News Article
1/15/202116:38Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/15/202116:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)
12/15/202008:30GlobeNewswire Inc.Auris Medical Provides Business Update
12/10/202008:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/07/202016:10GlobeNewswire Inc.Auris Medical Holding to Present at the 13th Annual LD Micro..
12/07/202015:50Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)
12/03/202017:26Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EARS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.652.852.562.70661,6200.02270.86%
1 Month2.923.072.512.73687,315-0.2473-8.47%
3 Months0.84216.5750.784.776,949,9211.83217.39%
6 Months0.95326.5750.72553.754,129,0911.72180.39%
1 Year1.516.5750.653.642,131,2581.1677.0%
3 Years10.0061.600.659.991,737,081-7.33-73.27%
5 Years80.40109.000.6512.121,209,563-77.73-96.68%

Auris Medical Description

Auris Medical Holding Ltd is a clinical-stage biopharmaceutical company. The company develops novel products for the treatment of inner ear disorders. It has two projects in advanced clinical development Keyzilen for the treatment of acute inner ear tinnitus and AM-111 for the treatment of acute inner ear hearing loss. It is developing Keyzilen for the treatment of acute inner ear (peripheral) tinnitus following traumatic cochlear injury or otitis media (middle ear infection). Keyzilen contains Esketamine hydrochloride, an N-Methyl-D-Aspartate (NMDA) receptor antagonist, formulated in a biocompatible and fully biodegradable gel. It is also developing AM-111 for the treatment of acute inner ear (sensorineural) hearing loss (ASNHL).
Your Recent History
NASDAQ
EARS
Auris Medi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210120 20:54:57